반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Positive Results from Rybrevant Trial Solidify Janssen’s Foothold in EGFR-Mutated NSCLC 09-08-2023
CureVac Highlights Shift in Seasonal Influenza Vaccines Development Pipeline 09-14-2023
Novo Nordisk’s Wegovy to Start Being Supplied by NHS in England 09-15-2023
Market Cap Rebound by Top 20 Biopharmaceutical Companies in Q2 2023 09-15-2023
Forxiga Flunks Primary Endpoint in DICTATE-AHF Trial 09-21-2023
Alvotech’s AVT05 in Phase III Rheumatoid Arthritis Study, as the Sole Candidate 09-21-2023
GSK’s Ojjaara Receives FDA Approval for Treating Myelofibrosis Patients with Anemia 09-21-2023
Clinical Trials Feasibility, Risk Assessment and Planning for Success – A Case Study 09-22-2023
질환별 Influence of Social Class on AIDS Incidence and Mortality in Brazil 09-12-2023
Heart Failure: Epidemiology Forecast to 2032 09-19-2023
Sepsis: 68-Market Analysis and Sales Forecast 09-21-2023
Can Steatosis-Associated Fibrosis Estimator Scores Improve Diagnosis of Nonalcoholic Fatty Liver Disease? 09-21-2023
New Evidence Shows Depression as a Major Risk for Type 2 Diabetes 09-22-2023
High Global Prevalence of HPV in Sexually Active Men 09-22-2023
The Burden of Hepatitis B and Hepatitis C-Related Illnesses 09-22-2023
컨퍼런스/심포지엄/학회 Disparity in the Distance Between Disease Prevalent Populations and Trial Locations 09-14-2023
Could Gilead's Trodelvy Be the Next TROP-2 Therapy Game-Changer in NSCLC Treatment 09-22-2023
반응형

+ Recent posts